0 likes | 1 Views
The Organ-On-Chip Market size was valued at USD 77.82 Million in 2024 and the total Organ-On-Chip revenue is expected to grow at a CAGR of 31.7% from 2025 to 2032, reaching nearly USD 704.37 Million.<br>
E N D
Organ-On-Chip Market global Analysis Report 2024-30 Published by: Chetana, HealthcareSpecialist
Market Size & Overview: The global Organ-On-Chip (OoC) market was valued at approximately USD 77.82 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 31.7%, reaching nearly USD 704.37 million by 2032. This technology replicates human organ functions on microchips, offering more accurate models for drug testing and disease research compared to traditional methods.
Market Growth & Opportunities The OoC market's growth is driven by the increasing demand for alternatives to animal testing, advancements in healthcare devices, and a rising number of organ transplants. Government funding and venture capital investments are supporting research and development in this field. For instance, in July 2024, the National Center for Advancing Translational Sciences (NCATS) awarded a $2 million grant to Emulate, Inc., to develop a fully automated research platform using its human Brain-Chip system. These advancements present significant opportunities for pharmaceutical companies and research institutions to enhance drug discovery and personalized medicine. Sample Request
Market Segmentation by Application • Toxicology Research • Physiological Model Development • Drug Discovery by End-User • Pharmaceutical & Biotechnology Companies • Academic Research Institutes • Others by Offering • Services • Products by Type • Liver-on-Chip • Lung-on-Chip • Kidney-on-Chip • Heart-on-Chip • Intestine-on-Chip • Brain-on-Chip • Others
Regional Analysis: • North America: Dominated the OoC market in 2024, accounting for approximately 40% of global revenue. This is attributed to advanced biotechnology sectors, robust research infrastructure, and supportive regulatory environments. • Europe: Anticipated to experience significant growth, driven by substantial investments in biomedical research and innovation across countries like Germany, the UK, Italy, France, and Spain. Initiatives such as Horizon Europe provide extensive funding and support for cutting-edge research, accelerating the development and commercialization of OoC systems. • Asia-Pacific (APAC): Identified as the fastest-growing region in the OoC market, due to increasing investments in biomedical research, rising adoption of personalized medicine approaches, and government initiatives supporting healthcare innovation.
Regional Analysis Customized Report Request
Merges and Acquisition The OoC market has witnessed significant mergers and acquisitions aimed at enhancing technological capabilities and expanding market reach: • MIMETAS and Organovo: MIMETAS, a Netherlands-based company, acquired US-based Organovo to expand their portfolio of advanced human tissue models, enhancing their position in the growing demand for personalized drug discovery solutions. • Emulate, Inc. and Research Institutions: Emulate, Inc. has partnered with research institutions to expand their footprint in the Asian market, aiming to develop more advanced organ-on-chip models for drug testing and clinical applications. Buy This Report
Thank You Get In Touch with US: MAXIMIZE MARKET RESEARCH PVT. LTD. 3rd Floor, Navale IT park Phase 2, Pune Banglore Highway, Narhe Pune, Maharashtra 411041, India. +91 9607365656 sales@maximizemarketresearch.com